Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
‘A disaster’: Roche CEO’s verdict on some COVID-19 antibody tests
While most of Roche’s coronavirus activity has been focused on testing, it is also studying if its older arthritis drug Actemra…
COVID-19: Disrupting the healthcare business’ practices
Dr RB Smarta, Chairman & Managing Director, Interlink writes about how the COVID-19 pandemic can prove to be a game-changer…
Bayer partners with Population Health Research Institute (PHRI) on global clinical research…
The two studies will evaluate the safety and efficacy of different combination therapies including Bayer’s chloroquine and…
Dak, Dawa aur Dua: A Made in India story
The alliance between India Post and India Pharma Inc is an interesting example of how intersectoral collaborations can optimise…
Merck boosts commercial viral vector and gene therapy manufacturing capacity
The new, € 100 million commercial facility is expected to open next year
Weizmann Institute of Science, Israel, to lead a collaboration on COVID-19 drug development
Dr London, heading the research, is collaborating with researchers from Oxford University; Memorial Sloan Kettering Cancer Center;…
Pharmasafe India 2020: Messe Frankfurt to focus on highlighting urgent anti-counterfeiting measures…
The 4th edition of Pharmasafe India 2020, which was earlier scheduled in April, has now been pushed ahead due to the nationwide…
World’s largest AI-powered, expert-curated platform for COVID-19 research launched
The COVID-19 platform will help researchers from various disciplines easily access and digest this information, supported by…
Israel’s OurCrowd leads $12 million investment to develop COVID-19 vaccine
MigVax, an affiliate of the Migal Galilee Research Institute, is pioneering the effort to develop a vaccine against COVID-19,…
MoHFW seeks export ban of anti-TB drugs
Delay in production and receipt of supply may cause acute shortage of these drugs, highlights Union Health Secretary